Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Fractyl Health, Inc. (GUTS)
USD0.92
+0.12 (+15.00%)
US NASDAQ Healthcare Biotechnology
Address
3 Van de Graaff Drive 1803
Burlington, MA, US
Burlington, MA, US
CEO
Harith Rajagopalan
Website
fractyl.com
IPO
2024-02-02
CIK 1572616 ISIN US35168W1036
Description
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.92
+0.12 (+15.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
2.34
Float Shares
29.38M
Free Float %
40.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +29.20% | +26.44% | +93.53% | +126.65% | -15.33% | -56.90% | -46.42% | -92.62% | -92.62% | -92.62% | -92.62% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (3 ratings, all time)
Buy
Price Targets & DCF
Current price
0.92
Low
2.00
+117.4%
Consensus
5.00
+443.5%
Median
5.00
+443.5%
High
8.00
+769.6%
DCF (Unlevered)
0.24
-73.6%
DCF (Levered)
0.26
-71.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
83% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 5 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 2 |
5.00
+443.5%
|
| All Time | 2 |
5.00
+443.5%
|
Quality scores
Altman Z-Score
-10.46
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-100.0%
-
EPS growth Biotechnology: +29.7%-14.8% Q1'26: +112.2% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: -437.7% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+74.1% Q1'26: +224.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.64× Q1'26: -0.74× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 4 EPS Ana. |
Dec 2027 2 Rev. Ana. 4 EPS Ana. |
Dec 2028 4 Rev. Ana. 2 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
120.0K
est: 148.0K (-18.9%)
|
93.0K
est: 50.0K (+86.0%)
|
—
est: 4.91M (-100.0%)
|
12.43M
9.39M – 17.55M
+153.3% YoY
|
22.33M
16.86M – 31.51M
+79.5% YoY
|
92.06M
92.06M – 92.06M
+312.4% YoY
|
252.49M
190.68M – 356.39M
+174.3% YoY
|
461.45M
348.48M – 651.35M
+82.8% YoY
|
| EBITDA |
-50.55M
est: 29.6K (-170,882.8%)
|
-92.85M
est: 10.0K (-928,732.9%)
|
-95.69M
est: 982.0K (-9,844.1%)
|
2.49M
1.88M – 3.51M
+153.3% YoY
|
4.46M
3.37M – 6.30M
+79.5% YoY
|
18.41M
18.41M – 18.41M
+312.4% YoY
|
50.50M
38.14M – 71.28M
+174.3% YoY
|
92.29M
69.70M – 130.27M
+82.8% YoY
|
| EBIT |
-50.84M
est: 29.6K (-171,849.0%)
|
-93.53M
est: 10.0K (-935,503.5%)
|
-96.82M
est: 982.0K (-9,959.1%)
|
2.49M
1.88M – 3.51M
+153.3% YoY
|
4.46M
3.37M – 6.30M
+79.5% YoY
|
18.41M
18.41M – 18.41M
+312.4% YoY
|
50.50M
38.14M – 71.28M
+174.3% YoY
|
92.29M
69.70M – 130.27M
+82.8% YoY
|
| Net Income |
-77.09M
est: -153.34M (+49.7%)
|
-68.69M
est: -121.31M (+43.4%)
|
-140.95M
est: -140.95M (+0.0%)
|
-51.28M
-59.03M – -43.53M
+63.6% YoY
|
-47.04M
-64.58M – -29.50M
+8.3% YoY
|
-28.05M
-30.66M – -25.45M
+40.4% YoY
|
5.05M
3.45M – 7.76M
+118.0% YoY
|
45.24M
30.84M – 69.44M
+795.0% YoY
|
| SGA |
—
est: 88.8K (-100.0%)
|
—
est: 30.0K (-100.0%)
|
21.15M
est: 2.95M (+618.0%)
|
7.46M
5.63M – 10.53M
+153.3% YoY
|
13.40M
10.12M – 18.91M
+79.5% YoY
|
55.24M
55.24M – 55.24M
+312.4% YoY
|
151.49M
114.41M – 213.84M
+174.3% YoY
|
276.87M
209.09M – 390.81M
+82.8% YoY
|
| EPS |
-1.98
est: -1.82 (-8.5%)
|
-1.62
est: -1.61 (-0.9%)
|
-1.86
est: -1.61 (-15.7%)
|
-0.65
-0.78 – -0.57
+59.5% YoY
|
-0.57
-0.85 – -0.39
+12.9% YoY
|
-0.37
-0.40 – -0.34
+34.8% YoY
|
0.07
0.05 – 0.10
+118.0% YoY
|
0.60
0.41 – 0.92
+795.0% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-24 | HC Wainwright & Co. | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-133.62M
OE per share TTM
-2.42
Owner's Yield
-229.17%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
45,949.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
20
Total invested
971.9K
Insider transactions (90d)
0
Beneficial owners (>5%)
16
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ajay Royan | 6.41M | 13.40% | — | 6.41M | — | 6.41M | IN | Delaware | 2024-11-13 | ↗ |
| 2 | Peter Thiel | 6.41M | 13.40% | — | 6.41M | — | 6.41M | IN | Delaware | 2024-11-13 | ↗ |
| 3 | Mithril GP LP | 5.16M | 10.80% | — | 5.16M | — | 5.16M | PN | Delaware | 2024-11-13 | ↗ |
| 4 | Mithril LP | 5.16M | 10.80% | — | 5.16M | — | 5.16M | PN | Delaware | 2024-11-13 | ↗ |
| 5 | GC Entrepreneurs Fund V, L.P. | 4.88M | 10.02% | — | 4.88M | — | 4.88M | PN | USA | 2024-02-16 | ↗ |
| 6 | General Catalyst GP V, LLC | 4.88M | 10.02% | — | 4.88M | — | 4.88M | OO | USA | 2024-02-16 | ↗ |
| 7 | General Catalyst Group V, L.P. | 4.88M | 10.02% | — | 4.88M | — | 4.88M | PN | USA | 2024-02-16 | ↗ |
| 8 | General Catalyst Partners V, L.P. | 4.88M | 10.02% | — | 4.88M | — | 4.88M | PN | USA | 2024-02-16 | ↗ |
| 9 | CVF, LLC | 4.67M | 9.80% | — | 4.67M | — | 4.67M | OO | Delaware | 2024-02-14 | ↗ |
| 10 | HCC Manager LLC | 4.67M | 9.80% | — | 4.67M | — | 4.67M | HC | Delaware | 2024-02-14 | ↗ |
| 11 | Lee S. Ainslie III | 4.25M | 8.90% | — | 4.25M | — | 4.25M | IN | Texas | 2024-11-14 | ↗ |
| 12 | Maverick Capital Management, LLC | 4.25M | 8.90% | — | 4.25M | — | 4.25M | HC | Texas | 2024-11-14 | ↗ |
| 13 | Maverick Capital, Ltd. | 4.25M | 8.90% | — | 4.25M | — | 4.25M | IA | Texas | 2024-11-14 | ↗ |
| 14 | Mithril II GP LP | 1.25M | 2.60% | — | 1.25M | — | 1.25M | PN | Delaware | 2024-11-13 | ↗ |
| 15 | Mithril II LP | 1.25M | 2.60% | — | 1.25M | — | 1.25M | PN | Delaware | 2024-11-13 | ↗ |
| 16 | Mithril II UGP LLC | 1.25M | 2.60% | — | 1.25M | — | 1.25M | OO | Delaware | 2024-11-13 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
20
-78 vs prev Q
New positions
7
Closed positions
85
Increased
10
Reduced
2
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | NANTAHALA CAPITAL MANAGEMENT, LLC | 10.85M -1.3M (-10.6%) | 23.86M +4.6M (+23.7%) | 16.78% -1.996 pp | 0.79% +0.119 pp | USD1.59 +38.4% | 2 qtrs — |
| 2 | SILVERARC CAPITAL MANAGEMENT, LLC | 9.84M -760.0K (-7.2%) | 21.65M +4.8M (+28.4%) | 15.22% -1.175 pp | 3.01% +0.734 pp | USD1.67 +31.7% | 8 qtrs — |
| 3 | 683 CAPITAL MANAGEMENT, LLC | 6.05M +1.4M (+30.1%) | 13.30M +5.9M (+80.0%) | 9.35% +2.162 pp | 0.58% +0.193 pp | USD2.33 -5.6% | 8 qtrs — |
| 4 | VANGUARD GROUP INC | 6.03M +4.1M (+213.8%) | 13.26M +10.2M (+334.2%) | 9.32% +6.352 pp | 0.00% +0.000 pp | USD2.29 -3.9% | 8 qtrs — |
| 5 | MARSHALL WACE, LLP | 5.93M +4.2M (+234.9%) | 13.04M +10.2M (+363.4%) | 9.17% +6.430 pp | 0.01% +0.009 pp | USD2.02 +8.9% | 2 qtrs — |
| 6 | WOODLINE PARTNERS LP | 5.51M +237.0 (+0.0%) | 12.11M +3.4M (+38.4%) | 8.52% +0.000 pp | 0.05% +0.006 pp | USD1.81 +21.5% | 8 qtrs — |
| 7 | CATALIO CAPITAL MANAGEMENT, LP | 5.49M +277.6K (+5.3%) | 12.08M +3.8M (+45.7%) | 8.49% +0.429 pp | 2.14% +0.603 pp | USD1.64 +34.1% | 5 qtrs — |
| 8 | GENERAL CATALYST GROUP MANAGEMENT, LLC | 4.88M +— (+0.0%) | 10.75M +3.0M (+38.4%) | 7.55% +0.000 pp | 4.85% +4.590 pp | USD1.62 +35.8% | 3 qtrs — |
| 9 | DEER MANAGEMENT CO. LLC | 4.77M +— (+0.0%) | 10.50M +2.9M (+38.4%) | 7.38% +0.000 pp | 1.02% +0.341 pp | USD7.45 -70.5% | 8 qtrs — |
| 10 | HCC MANAGER LLC | 4.67M -1.0 (+0.0%) | 10.28M +2.9M (+38.4%) | 7.23% +0.000 pp | 100.00% +0.000 pp | USD7.45 -70.5% | 8 qtrs — |
| 11 | MAVERICK CAPITAL LTD | 4.25M +— (+0.0%) | 9.35M +2.6M (+38.4%) | 6.57% +0.000 pp | 0.10% +0.010 pp | USD7.45 -70.5% | 8 qtrs — |
| 12 | ALYESKA INVESTMENT GROUP, L.P. | 3.81M -1.8M (-32.6%) | 8.38M -600.0K (-6.7%) | 5.89% -2.844 pp | 0.02% -0.004 pp | USD1.59 +38.4% | 2 qtrs — |
| 13 | GOLDMAN SACHS GROUP INC | 3.43M +2.9M (+598.4%) | 7.54M +6.8M (+866.3%) | 5.30% +4.539 pp | 0.00% +0.001 pp | USD2.14 +2.8% | 7 qtrs — |
| 14 | PALE FIRE CAPITAL SE | 3.21M +3.2M (+100.0%) | 7.06M +7.1M (+100.0%) | 4.96% +4.965 pp | 0.47% +0.474 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 15 | BLACKROCK, INC. | 2.08M +1.3M (+174.1%) | 4.58M +3.4M (+279.3%) | 3.22% +2.047 pp | 0.00% +0.000 pp | USD2.30 -4.3% | 6 qtrs — |
| 16 | ATOM INVESTORS LP | 1.88M +1.9M (+100.0%) | 4.14M +4.1M (+100.0%) | 2.91% +2.913 pp | 0.33% +0.329 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 17 | RENAISSANCE TECHNOLOGIES LLC | 1.86M +1.1M (+139.9%) | 4.10M +2.9M (+231.9%) | 2.88% +1.680 pp | 0.01% +0.005 pp | USD1.95 +12.8% | 2 qtrs — |
| 18 | JANE STREET GROUP, LLC | 1.86M +1.9M (+100.0%) | 4.10M +4.1M (+100.0%) | 2.88% +2.881 pp | 0.00% +0.001 pp | USD2.20 +0.0% | 8 qtrs — |
| 19 | MILLENNIUM MANAGEMENT LLC | 1.86M +1.5M (+356.6%) | 4.10M +3.4M (+531.8%) | 2.88% +2.249 pp | 0.00% +0.001 pp | USD2.07 +6.3% | 8 qtrs — |
| 20 | M28 CAPITAL MANAGEMENT LP | 1.86M +— (+0.0%) | 4.08M +1.1M (+38.4%) | 2.87% +0.000 pp | 2.97% -1.371 pp | USD7.45 -70.5% | 8 qtrs — |
| 21 | TWO SIGMA INVESTMENTS, LP | 1.84M +1.8M (+100.0%) | 4.05M +4.0M (+100.0%) | 2.85% +2.846 pp | 0.01% +0.006 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 22 | D. E. SHAW & CO., INC. | 1.44M +1.1M (+390.2%) | 3.17M +2.7M (+578.3%) | 2.23% +1.776 pp | 0.00% +0.002 pp | USD2.08 +5.8% | 2 qtrs — |
| 23 | ADAR1 CAPITAL MANAGEMENT, LLC | 1.43M +1.4M (+100.0%) | 3.14M +3.1M (+100.0%) | 2.21% +2.210 pp | 0.23% +0.231 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 24 | TWO SIGMA ADVISERS, LP | 1.30M +1.3M (+100.0%) | 2.86M +2.9M (+100.0%) | 2.01% +2.009 pp | 0.01% +0.006 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 25 | GEODE CAPITAL MANAGEMENT, LLC | 1.26M +968.9K (+328.5%) | 2.78M +2.3M (+493.2%) | 1.95% +1.499 pp | 0.00% +0.000 pp | USD2.25 -2.2% | 8 qtrs — |
| 26 | BANK OF AMERICA CORP /DE/ | 1.19M +1.1M (+1,245.1%) | 2.62M +2.5M (+1,761.2%) | 1.84% +1.663 pp | 0.00% +0.000 pp | USD2.29 -3.9% | 8 qtrs — |
| 27 | NEWTYN MANAGEMENT, LLC | 1.13M +1.1M (+100.0%) | 2.49M +2.5M (+100.0%) | 1.75% +1.754 pp | 0.26% +0.262 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 28 | UBS GROUP AG | 1.11M +361.4K (+48.0%) | 2.45M +1.3M (+104.8%) | 1.72% +0.559 pp | 0.00% +0.000 pp | USD1.80 +22.2% | 7 qtrs — |
| 29 | IKARIAN CAPITAL, LLC | 1.10M -700.0K (-38.9%) | 2.42M -442.0K (-15.4%) | 1.70% -1.083 pp | 0.19% -0.100 pp | USD1.59 +38.4% | 2 qtrs — |
| 30 | LOGOS GLOBAL MANAGEMENT LP | 1.10M +600.0K (+120.0%) | 2.42M +1.6M (+204.4%) | 1.70% +0.928 pp | 0.15% +0.075 pp | USD1.92 +14.6% | 2 qtrs — |
| 31 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 852.3K -73.5K (-7.9%) | 1.88M +403.1K (+27.4%) | 1.32% -0.114 pp | 0.00% +0.000 pp | USD7.12 -69.1% | 8 qtrs — |
| 32 | CM MANAGEMENT, LLC | 800.0K +200.0K (+33.3%) | 1.76M +806.0K (+84.5%) | 1.24% +0.309 pp | 1.48% +0.688 pp | USD1.74 +26.4% | 2 qtrs — |
| 33 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 799.5K +799.5K (+100.0%) | 1.76M +1.8M (+100.0%) | 1.24% +1.237 pp | 0.00% +0.000 pp | USD2.20 +0.0% | 5 qtrs — |
| 34 | MORGAN STANLEY | 656.5K +226.3K (+52.6%) | 1.44M +760.2K (+111.1%) | 1.02% +0.350 pp | 0.00% +0.000 pp | USD2.30 -4.3% | 8 qtrs — |
| 35 | WALLEYE CAPITAL LLC | 592.1K +592.1K (+100.0%) | 1.30M +1.3M (+100.0%) | 0.92% +0.916 pp | 0.00% +0.004 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 36 | STATE STREET CORP | 512.7K +471.9K (+1,156.6%) | 1.13M +1.1M (+1,638.7%) | 0.79% +0.730 pp | 0.00% +0.000 pp | USD2.30 -4.3% | 8 qtrs — |
| 37 | DIAMETRIC CAPITAL, LP | 503.4K +377.8K (+300.7%) | 1.11M +907.7K (+454.4%) | 0.78% +0.584 pp | 0.30% +0.223 pp | USD2.06 +6.8% | 5 qtrs — |
| 38 | BURKEHILL GLOBAL MANAGEMENT, LP | 500.0K +— (+0.0%) | 1.10M +305.0K (+38.4%) | 0.77% +0.000 pp | 0.07% +0.027 pp | USD1.59 +38.4% | 2 qtrs — |
| 39 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 464.7K +464.7K (+100.0%) | 1.05M +1.0M (+100.0%) | 0.72% +0.719 pp | 0.01% +0.011 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 40 | SOLEUS CAPITAL MANAGEMENT, L.P. | 400.0K -2.1M (-84.0%) | 880.0K -3.1M (-77.9%) | 0.62% -3.248 pp | 0.03% -0.168 pp | USD1.59 +38.4% | 2 qtrs — |
| 41 | ROSALIND ADVISORS, INC. | 385.7K -4.6M (-92.3%) | 848.6K -7.1M (-89.3%) | 0.60% -7.137 pp | 0.30% -2.419 pp | USD1.59 +38.4% | 2 qtrs — |
| 42 | POINT72 ASSET MANAGEMENT, L.P. | 365.2K -1.8M (-83.3%) | 803.4K -2.7M (-76.9%) | 0.56% -2.819 pp | 0.00% -0.005 pp | USD1.59 +38.4% | 2 qtrs — |
| 43 | QUADRATURE CAPITAL LTD | 290.7K +277.2K (+2,047.1%) | 639.6K +618.2K (+2,889.6%) | 0.45% +0.429 pp | 0.01% +0.006 pp | USD2.17 +1.4% | 2 qtrs — |
| 44 | BOOTHBAY FUND MANAGEMENT, LLC | 275.2K -380.0K (-58.0%) | 605.5K -436.3K (-41.9%) | 0.43% -0.588 pp | 0.01% -0.006 pp | USD1.59 +38.4% | 2 qtrs — |
| 45 | BARCLAYS PLC | 243.3K +195.5K (+409.0%) | 535.2K +414.3K (+342.6%) | 0.38% +0.279 pp | 0.00% +0.000 pp | USD2.08 +5.8% | 7 qtrs — |
| 46 | CITADEL ADVISORS LLC | 229.0K -1.6M (-87.2%) | 503.8K -2.3M (-82.2%) | 0.35% -2.403 pp | 0.00% 0.000 pp | USD1.59 +38.4% | 8 qtrs — |
| 47 | NORTHERN TRUST CORP | 215.9K +201.2K (+1,374.6%) | 474.9K +451.7K (+1,940.2%) | 0.33% +0.311 pp | 0.00% +0.000 pp | USD2.25 -2.2% | 8 qtrs — |
| 48 | PEAK6 LLC | 200.0K -50.0K (-20.0%) | 440.0K +42.5K (+10.7%) | 0.31% -0.077 pp | 0.00% +0.000 pp | USD1.59 +38.4% | 2 qtrs — |
| 49 | GSA CAPITAL PARTNERS LLP | 189.2K +10.2K (+5.7%) | 416.0K +131.0K (+46.0%) | 0.29% +0.016 pp | 0.04% +0.012 pp | USD1.62 +35.8% | 2 qtrs — |
| 50 | OMERS ADMINISTRATION CORP | 179.3K +179.3K (+100.0%) | 394.5K +394.5K (+100.0%) | 0.28% +0.277 pp | 0.00% +0.003 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 51 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 178.0K +178.0K (+100.0%) | 391.7K +391.7K (+100.0%) | 0.28% +0.275 pp | 0.00% +0.003 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 52 | HUDSON BAY CAPITAL MANAGEMENT LP | 171.8K +171.8K (+100.0%) | 378.0K +378.0K (+100.0%) | 0.27% +0.266 pp | 0.00% +0.001 pp | USD2.20 +0.0% | 3 qtrs — |
| 53 | CERITY PARTNERS LLC | 163.5K +149.9K (+1,105.2%) | 359.7K +338.1K (+1,567.6%) | 0.25% +0.232 pp | 0.00% +0.001 pp | USD2.19 +0.5% | 6 qtrs — |
| 54 | SQUAREPOINT OPS LLC | 147.7K +147.7K (+100.0%) | 324.9K +324.9K (+100.0%) | 0.23% +0.228 pp | 0.00% +0.000 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 55 | SHAY CAPITAL LLC | 136.6K -148.6K (-52.1%) | 300.5K -153.0K (-33.7%) | 0.21% -0.230 pp | 0.03% -0.008 pp | USD1.59 +38.4% | 2 qtrs — |
| 56 | QUANTBOT TECHNOLOGIES LP | 120.4K +120.4K (+100.0%) | 265.0K +265.0K (+100.0%) | 0.19% +0.186 pp | 0.01% +0.009 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 57 | QUBE RESEARCH & TECHNOLOGIES LTD | 117.6K +94.7K (+413.8%) | 258.8K +222.4K (+610.9%) | 0.18% +0.147 pp | 0.00% +0.000 pp | USD2.09 +5.3% | 3 qtrs — |
| 58 | PRELUDE CAPITAL MANAGEMENT, LLC | 80.6K +45.8K (+131.9%) | 177.3K +122.1K (+220.9%) | 0.12% +0.071 pp | 0.01% +0.009 pp | USD1.94 +13.4% | 2 qtrs — |
| 59 | ADVISOR GROUP HOLDINGS, INC. | 75.5K -1.3K (-1.7%) | 166.0K +87.0K (+110.2%) | 0.12% -0.002 pp | 0.00% +0.000 pp | USD1.63 +35.0% | 5 qtrs — |
| 60 | VIRTU FINANCIAL LLC | 69.4K +69.4K (+100.0%) | 153.0K +153.0K (+100.0%) | 0.11% +0.107 pp | 0.01% +0.006 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 61 | CONSERVEST CAPITAL ADVISORS, INC. | 64.1K +— (+0.0%) | 141.1K +39.1K (+38.4%) | 0.10% +0.000 pp | 0.01% +0.003 pp | USD2.06 +6.8% | 5 qtrs — |
| 62 | CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 64.0K +64.0K (+100.0%) | 141.0K +141.0K (+100.0%) | 0.10% +0.099 pp | 0.00% +0.000 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 63 | BALYASNY ASSET MANAGEMENT L.P. | 60.2K +60.2K (+100.0%) | 132.5K +132.5K (+100.0%) | 0.09% +0.093 pp | 0.00% +0.000 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 64 | VERITION FUND MANAGEMENT LLC | 54.9K +54.9K (+100.0%) | 120.8K +120.8K (+100.0%) | 0.08% +0.085 pp | 0.00% +0.001 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 65 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 54.5K +9.0K (+19.8%) | 119.9K +47.6K (+65.7%) | 0.08% +0.014 pp | 0.00% +0.001 pp | USD2.48 -11.3% | 6 qtrs — |
| 66 | XTX TOPCO LTD | 51.9K +5.9K (+12.8%) | 114.3K +41.0K (+56.0%) | 0.08% +0.009 pp | 0.00% -0.001 pp | USD1.66 +32.5% | 2 qtrs — |
| 67 | HIGHTOWER ADVISORS, LLC | 51.4K +— (+0.0%) | 113.2K +31.4K (+38.4%) | 0.08% +0.000 pp | 0.00% +0.000 pp | USD1.85 +18.9% | 6 qtrs — |
| 68 | SCHONFELD STRATEGIC ADVISORS LLC | 50.2K +50.2K (+100.0%) | 110.4K +110.4K (+100.0%) | 0.08% +0.078 pp | 0.00% +0.001 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 69 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 49.1K +49.1K (+100.0%) | 108.1K +108.1K (+100.0%) | 0.08% +0.076 pp | 0.00% +0.002 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 70 | FNY INVESTMENT ADVISERS, LLC | 48.7K +28.7K (+143.3%) | 107.0K +76.0K (+245.2%) | 0.08% +0.035 pp | 0.03% +0.020 pp | USD1.95 +12.8% | 2 qtrs — |
| 71 | COMMONWEALTH EQUITY SERVICES, LLC | 38.7K +38.7K (+100.0%) | 85.1K +85.1K (+100.0%) | 0.06% +0.060 pp | 0.00% +0.000 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 72 | LIGHTHOUSE INVESTMENT PARTNERS, LLC | 36.3K +36.3K (+100.0%) | 79.9K +79.9K (+100.0%) | 0.06% +0.056 pp | 0.00% +0.002 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 73 | CITIGROUP INC | 35.1K +34.9K (+16,064.1%) | 77.2K +76.8K (+22,267.2%) | 0.05% +0.054 pp | 0.00% +0.000 pp | USD2.20 +0.0% | 8 qtrs — |
| 74 | CHICAGO PARTNERS INVESTMENT GROUP LLC | 31.0K +— (+0.0%) | 64.8K +25.1K (+63.3%) | 0.05% +0.000 pp | 0.00% +0.001 pp | USD1.19 +84.9% | 4 qtrs — |
| 75 | JUMP FINANCIAL, LLC | 26.0K +26.0K (+100.0%) | 57.2K +57.2K (+100.0%) | 0.04% +0.040 pp | 0.00% +0.001 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 76 | SCIENTECH RESEARCH LLC | 18.0K -12.6K (-41.1%) | 39.6K -9.0K (-18.5%) | 0.03% -0.019 pp | 0.02% +0.008 pp | USD1.59 +38.4% | 2 qtrs — |
| 77 | CREATIVE PLANNING | 17.5K +17.5K (+100.0%) | 38.5K +38.5K (+100.0%) | 0.03% +0.027 pp | 0.00% +0.000 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 78 | CENTIVA CAPITAL, LP | 17.4K -31.9K (-64.7%) | 38.3K -40.1K (-51.2%) | 0.03% -0.049 pp | 0.00% 0.000 pp | USD1.59 +38.4% | 2 qtrs — |
| 79 | BRONTE CAPITAL MANAGEMENT PTY LTD. | 16.9K +16.9K (+100.0%) | 37.2K +37.2K (+100.0%) | 0.03% +0.026 pp | 0.00% +0.004 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 80 | PARKSIDE FINANCIAL BANK & TRUST | 16.3K +— (+0.0%) | 35.9K +9.9K (+38.4%) | 0.03% +0.000 pp | 0.00% +0.001 pp | USD1.98 +11.1% | 5 qtrs — |
| 81 | RAYMOND JAMES FINANCIAL INC | 15.1K +2.4K (+18.7%) | 33.2K +13.0K (+64.2%) | 0.02% +0.004 pp | 0.00% +0.000 pp | USD2.08 +5.8% | 5 qtrs — |
| 82 | TOWER RESEARCH CAPITAL LLC (TRC) | 14.8K +9.6K (+183.5%) | 32.5K +24.2K (+292.3%) | 0.02% +0.015 pp | 0.00% +0.001 pp | USD2.19 +0.5% | 8 qtrs — |
| 83 | R SQUARED LTD | 14.0K +3.4K (+31.6%) | 30.8K +13.9K (+82.1%) | 0.02% +0.005 pp | 0.01% +0.007 pp | USD1.76 +25.0% | 3 qtrs — |
| 84 | VICTORY CAPITAL MANAGEMENT INC | 13.1K +13.1K (+100.0%) | 28.7K +28.7K (+100.0%) | 0.02% +0.020 pp | 0.00% +0.000 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 85 | LPL FINANCIAL LLC | 10.4K +— (+0.0%) | 22.9K +6.4K (+38.4%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD1.59 +38.4% | 2 qtrs — |
| 86 | BANK OF NEW YORK MELLON CORP | 10.1K +10.1K (+100.0%) | 22.2K +22.2K (+100.0%) | 0.02% +0.016 pp | 0.00% +0.000 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 87 | LARSON FINANCIAL GROUP LLC | 6.0K +6.0K (+100.0%) | 13.1K +13.1K (+100.0%) | 0.01% +0.009 pp | 0.00% +0.000 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 88 | TRIUMPH CAPITAL MANAGEMENT | 3.0K +— (+0.0%) | 6.6K +1.8K (+38.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.59 +38.4% | 2 qtrs — |
| 89 | MILLINGTON FINANCIAL ADVISORS, LLC | 12.6K +12.6K (+100.0%) | 5.2K +5.2K (+100.0%) | 0.02% +0.019 pp | 0.00% +0.002 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 90 | ST. JOHNS INVESTMENT MANAGEMENT COMPANY, LLC | 2.0K +— (+0.0%) | 4.4K +1.2K (+38.4%) | 0.00% +0.000 pp | 0.00% +0.001 pp | USD1.61 +36.6% | 3 qtrs — |
| 91 | SOUND INCOME STRATEGIES, LLC | 2.0K +971.0 (+97.1%) | 3.8K +2.4K (+168.9%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD1.89 +16.4% | 2 qtrs — |
| 92 | CIBC PRIVATE WEALTH GROUP, LLC | 1.2K +1.2K (+100.0%) | 2.6K +2.6K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD2.20 +0.0% | 1 qtrs NEW |
| 93 | JPMORGAN CHASE & CO | 934.00 -49.8K (-98.2%) | 2.1K -78.6K (-97.5%) | 0.00% -0.102 pp | 0.00% +0.000 pp | USD1.59 +38.4% | 8 qtrs — |
| 94 | BNP PARIBAS ARBITRAGE, SNC | 802.00 -113.0 (-12.3%) | 1.8K +309.0 (+21.2%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD3.78 -41.8% | 7 qtrs — |
| 95 | JONES FINANCIAL COMPANIES LLLP | 500.00 +— (+0.0%) | 1.1K +430.0 (+64.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.59 +38.4% | 2 qtrs — |
| 96 | ALLWORTH FINANCIAL LP | 149.00 +149.0 (+100.0%) | 328.00 +328.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.19 +0.5% | 1 qtrs NEW |
| 97 | SBI SECURITIES CO., LTD. | 120.00 +— (+0.0%) | 264.00 +73.0 (+38.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.62 +35.8% | 3 qtrs — |
| 98 | OPTIVER HOLDING B.V. | 14.00 +— (+0.0%) | 31.00 +9.0 (+40.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.57 +40.1% | 2 qtrs — |
| 99 | ARROWPOINT INVESTMENT PARTNERS (SINGAPORE) PTE. LTD. | — -35.0K (-100.0%) | — -55.7K (-100.0%) | 0.00% -0.054 pp | 0.00% -0.056 pp | USD— | 2 qtrs SOLD |
| 100 | ALPHABET INC. | — -662.6K (-100.0%) | — -1.1M (-100.0%) | 0.00% -1.025 pp | 0.00% -0.044 pp | USD— | 8 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 11 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 983.3K | 0.05% |
| 2 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 7.1K | 0.03% |
| 3 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 19.4K | 0.17% |
| 4 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 1.4K | 0.17% |
| 5 | Vanguard Total Stock Market ETF VTI | 0.00% | 3.32M | 0.03% |
| 6 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 7.3K | 0.22% |
| 7 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 4.0K | 0.22% |
| 8 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 1.6K | 0.22% |
| 9 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 176.33 | 0.22% |
| 10 | Vanguard Conservative Income ETF Portfolio VCIP.TO | 0.00% | 24.81 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
1.04M
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+1,036,800
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-12 | Smith Weber Lara | Officer | A-Award | A | Stock Option | 1,036,800 | 2.00 | 2.07M | 1,036,800 | D | ↗ |
| 2025-12-15 | Toomey Sarah | Officer | A-Award | A | Stock Option (right to buy) | 743,913 | 2.24 | 1.67M | 743,913 | D | ↗ |
| 2025-12-15 | Rajagopalan Harith | Director / Officer | A-Award | A | Stock Option (right to buy) | 2,486,302 | 2.24 | 5.57M | 2,486,302 | D | ↗ |
| 2025-12-15 | Caplan Jay David | Officer | A-Award | A | Stock Option (right to buy) | 845,226 | 2.24 | 1.89M | 845,226 | D | ↗ |
| 2025-12-04 | Rajagopalan Harith | Director / Officer | P-Purchase | A | Common Stock | 10,416 | 1.92 | 20.0K | 501,745 | D | ↗ |
| 2025-09-02 | Thompson Christopher Charles | Director | A-Award | A | Stock Option | 45,000 | 0.98 | 44.0K | 45,000 | D | ↗ |
| 2025-09-02 | Sheffield Ian | Director | A-Award | A | Stock Option | 45,000 | 0.98 | 44.0K | 45,000 | D | ↗ |
| 2025-06-11 | SCHULMAN AMY W | Director | A-Award | A | Stock Option | 22,500 | 2.27 | 51.1K | 22,500 | D | ↗ |
| 2025-06-11 | Royan Ajay | Director / 10% Owner | A-Award | A | Stock Option | 22,500 | 2.27 | 51.1K | 22,500 | D | ↗ |
| 2025-06-11 | MEANWELL CLIVE | Director | A-Award | A | Stock Option | 22,500 | 2.27 | 51.1K | 22,500 | D | ↗ |
| 2025-06-11 | Elia Marc | Director | A-Award | A | Stock Option | 22,500 | 2.27 | 51.1K | 22,500 | D | ↗ |
| 2025-06-11 | Conaway Samuel | Director | A-Award | A | Stock Option | 22,500 | 2.27 | 51.1K | 22,500 | D | ↗ |
| 2025-06-11 | Barnes Kelly Ann | Director | A-Award | A | Stock Option | 22,500 | 2.27 | 51.1K | 22,500 | D | ↗ |
| 2025-06-11 | BRADLEY WILLIAM | Director | A-Award | A | Stock Option | 22,500 | 2.27 | 51.1K | 22,500 | D | ↗ |
| 2024-02-06 | General Catalyst GP V, LLC | 10% Owner | C-Conversion | D | Series A Preferred Stock | 66,897 | 0.00 | — | 0 | — | ↗ |
| 2024-02-06 | CVF, LLC | 10% Owner | P-Purchase | A | Common Stock | 333,333 | 15.00 | 5.00M | 4,673,870 | — | ↗ |
| 2024-02-06 | Bessemer Venture Partners VII L.P. | 10% Owner | C-Conversion | D | Series B Preferred Stock | 3,161,709 | 0.00 | — | 0 | — | ↗ |
| 2024-02-06 | AMERICAN INTERNATIONAL GROUP, INC. | 10% Owner | C-Conversion | A | Common Stock | 199,257 | 0.00 | — | 199,257 | — | ↗ |
| 2024-02-01 | Mithril LP | 10% Owner | — | D | Series C-2 Preferred Stock | 3,030,193 | 0.00 | — | 0 | — | ↗ |
| 2024-02-01 | General Catalyst GP V, LLC | 10% Owner | — | I | Series C-1 Preferred Stock | 12,785 | 0.00 | — | 0 | — | ↗ |
| 2024-02-01 | CVF, LLC | 10% Owner | — | D | Series D Preferred Stock | 4,090,872 | 0.00 | — | 0 | — | ↗ |
| 2024-02-01 | Bessemer Venture Partners VII L.P. | 10% Owner | — | I | Series A Preferred Stock | 910,190 | 0.00 | — | 0 | — | ↗ |
| 2024-02-01 | BRADLEY WILLIAM | Director | — | D | Stock Option | 6,989 | 8.59 | 60.0K | 0 | — | ↗ |
| 2024-02-01 | AMERICAN INTERNATIONAL GROUP, INC. | 10% Owner | — | I | Series F Preferred Shares | 37,623 | 0.00 | — | 0 | — | ↗ |
| 2023-07-11 | CVF, LLC | 10% Owner | — | D | Common Stock Warrant | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
72.19M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Harith Rajagopalan, M.D., Ph.D. Chief Executive Officer | 610.0K | — | — | 5.44M | 366.0K | 422.00 | 6.41M | 84.78% | ↗ |
| 2 | 2025 | Jay D. Caplan President and Chief Product Officer | 475.0K | — | — | 2.38M | 190.0K | 1.9K | 3.04M | 78.09% | ↗ |
| 3 | 2025 | Sarah Toomey General Counsel and Corporate Secretary | 445.0K | — | — | 1.81M | 193.0K | 648.00 | 2.45M | 73.89% | ↗ |
| 4 | 2024 | Harith Rajagopalan, M.D., Ph.D. Chief Executive Officer | 604.5K | — | — | 3.98M | 274.5K | 600.00 | 4.86M | 81.89% | ↗ |
| 5 | 2024 | Jay D. Caplan President and Chief Product Officer | 468.1K | — | — | 1.59M | 142.5K | 600.00 | 2.20M | 72.20% | ↗ |
| 6 | 2024 | Lisa A. Davidson Chief Financial Officer and Treasurer | 445.4K | — | — | 1.39M | 135.0K | 600.00 | 1.97M | 70.54% | ↗ |
| 7 | 2023 | Harith Rajagopalan, M.D., Ph.D. Chief Executive Officer | 550.0K | — | 2.43M | 268.0K | 313.5K | 270.00 | 3.56M | 75.75% | ↗ |
| 8 | 2023 | Jay D. Caplan President and Chief Product Officer | 400.0K | — | 2.10M | 220.5K | 154.0K | 1.2K | 2.87M | 80.68% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Harith Rajagopalan | Co-Founder, Chief Executive Officer & Director | 976.4K | — |
| Jay D. Caplan BSEE | Co-Founder, Chief Product Officer & President | 666.9K | male |
| Sarah S. Toomey | General Counsel & Corporate Secretary | 638.6K | female |
| Lara Smith Weber | Chief Financial Officer & Treasurer | 581.0K | female |
| Brian Luque | Head of Investor Relations & Corporate Development | — | male |
| Jon Fitzgerald | Senior Vice President of Regulatory, Quality & Clinical | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GUTS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
